Re‐expression of microRNA‐150 induces EBV‐positive Burkitt lymphoma differentiation by modulating c‐Myb in vitro

@article{Chen2013ReexpressionOM,
  title={Re‐expression of microRNA‐150 induces EBV‐positive Burkitt lymphoma differentiation by modulating c‐Myb in vitro},
  author={Shaohong Chen and Z. Wang and Xinzhen Dai and Jianhua Pan and J. Ge and Xiqun Han and Zijing Wu and X. Zhou and Tong Zhao},
  journal={Cancer Science},
  year={2013},
  volume={104},
  pages={826 - 834}
}
  • Shaohong Chen, Z. Wang, +6 authors Tong Zhao
  • Published 2013
  • Biology, Medicine
  • Cancer Science
  • Burkitt lymphoma (BL) is a highly aggressive B‐cell lymphoma that includes two forms of BL differing in Epstein–Barr virus (EBV) infection status, EBV‐positive and EBV‐negative. Although many efforts, such as high‐intensity, short‐duration combination chemotherapy, have been devoted to improving therapy for this rapidly proliferating neoplasm, there are still significant treatment‐associated toxicities. Therefore, there remains a need for novel effective therapeutic strategies. MicroRNAs play a… CONTINUE READING
    Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
    • 18
    • Highly Influenced
    Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.
    • 11
    • Open Access
    FAMLF is a target of miR-181b in Burkitt lymphoma
    • 5
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 62 REFERENCES
    MicroRNAs in normal and malignant hematopoiesis
    • 256
    The role of microRNA-150 as a tumor suppressor in malignant lymphoma
    • 145
    • Open Access
    MicroRNA signatures in B-cell lymphomas
    • 47
    • Open Access